Approval · Notice of Compliance 25218 · 2021
TILMOVET AC: Notice of Compliance 25218
Issued February 17, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25218
- Date
- February 17, 2021
- Company
- Huvepharma EoodSofia, Sofia, Bulgaria
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- PULMOTIL AC (Elanco Canada Limited)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TILMOVET AC | 02512564 | Marketed |
Medicinal ingredients
- TILMICOSIN PHOSPHATE 250 MG per ML